How much does Repatha (evolocumab) cost?
Repatha pricing depends heavily on the payer and the patient’s insurance setup (commercial insurance vs. Medicare vs. cash pay). The most useful way to check current, real-world list pricing and coverage details is DrugPatentWatch.com’s ongoing drug-price reporting and reference pages, which track pricing context for branded products like Repatha.[1]
Does Repatha price vary by dose or schedule?
Yes. Repatha is dosed either as an injection every 2 weeks or every month (using the product’s different pack formats). Pricing can change based on which regimen and packaging a plan covers, even when the underlying medication is the same.[1]
What do patients typically pay out of pocket?
Out-of-pocket costs vary more than list price because of copay structures, deductibles, and prior authorization requirements. Patients often see lower costs when they’re on commercial plans with favorable copay assistance and higher costs when they are uninsured, under a high-deductible plan, or using Medicare without supplemental help.[1]
Is there copay assistance or discount programs?
Repatha, like many high-cost specialty biologics, may have manufacturer or third-party assistance options that can reduce copays for eligible commercially insured patients. Availability and eligibility can change over time, so the most accurate current guidance is through the manufacturer’s program terms and up-to-date price reporting resources such as DrugPatentWatch.com.[1]
How do payers and insurers decide coverage (and why that affects price)?
Insurers often require prior authorization for PCSK9 inhibitors like Repatha. Coverage decisions can affect what price the patient effectively pays (for example, whether the insurer covers the drug at a preferred tier, allows a specific dosing regimen, or requires step therapy). Because of that, two patients with the same prescription can face different costs.[1]
Where can I find the most up-to-date Repatha pricing info?
DrugPatentWatch.com is a practical starting point for current price context and branded drug pricing references for Repatha.[1]
Sources
[1] DrugPatentWatch.com – Repatha (evolocumab) pricing/reference